American Autonomic Society

12th International Symposium on the
Autonomic Nervous System

Satellite Symposium


Models to Understand Development and Maintenance
of the Autonomic Nervous System

Friday, October 12, 2001
5:00 7:30 PM

Westin Mission Hills Resort
Palm Springs, California

 Preliminary Program


(Click here to download in Word Format)

5:00 5:45 PM     Overview of FD and other HSANs Genetics  and  pathophysiology
                                Felicia B. Axelrod, M.D. (Chair)
New York University School of Medicine

 5:45 6:15 PM     Genetics of FD - Tissue specific expression of the IKBKAP gene mutation
Susan A. Slaugenhaupt, Ph.D.
Harvard Medical School

 6:15 6:45 PM     Genetics of HSAN IV Mutations in TrkA 
Yasuhiro Indo, M.D., Ph.D.
Kumamoto University School of Medicine

 6:45 7:15 PM     Autonomic assessment and evaluation of FD and HSANs with standardized autonomic tests
Max J. Hilz, M.D., Ph.D.
New York University School of Medicine
University Erlangen-Nuremberg

7:15 7:30 PM     Questions to the Panel 

This program is supported in part by an unrestricted educational grant provided by the Dysautonomia Foundation, Inc.  This support is gratefully acknowledged.

Joslin Diabetes Center, Boston adheres to ACCME Standards regarding industry support of continuing medical education programs.  Disclosure of faculty commercial relationships, if any, will be made known at the program.


This accredited program has been developed for neurologists, cardiologists, endocrinologists, diabetologists, pharmacologists and urologists involved in the evaluation and management of human autonomic disorders.  The educational objectives of this symposium are for the attendees to:

      Understand the pathophysiology of genetic autonomic/sensory disorders and associate genotypes and phenotypes.

      Enhance knowledge of the clinical features of these disorders.

      Learn about the new genetic techniques for diagnosing genetic autonomic/sensory disorders.

      Learn neurodiagnostic techniques to differentiate between the genetic autonomic/sensory disorders.

      Increase awareness of the therapies for genetic autonomic/sensory disorders.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Joslin Diabetes Center, Boston and the American Autonomic Society. The Joslin Diabetes Center, Boston is accredited by the ACCME to provide continuing medical education for physicians. The Joslin Diabetes Center, Boston designates this CME activity for a maximum of 2.5 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association.  Each physician should claim only those hours of credit that he/she actually spent in the educational activity.